PATENT CLAIM ANALYSIS

Application Number: 15997238
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "093400"]

Abstract:
A method of targeting bacterially-derived, intact minicells to specific, non-phagocytic mammalian cells employs bispecific ligands to deliver nucleic acids efficiently to the mammalian cells. Bispecific ligands, comprising (i) a first arm that carries specificity for a bacterially-derived minicell surface structure and (ii) a second arm that carries specificity for a non-phagocytic mammalian cell surface receptor are useful for targeting minicells to specific, non-phagocytic mammalian cells and causing endocytosis of minicells by non-phagocytic cells.

Claim (Index 9):
A method according to  claim 1 , wherein said bispecific ligand comprises an antibody or antibody fragment.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 94.0
- Lexical Diversity: 1.76596
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10581990', '14820464', '11211098', '15675548', '14983126']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7918916423658686
- 35 USC 102 Novelty (BERT): 0.6463929211624282
- Combined Prediction Score: 0.7773417702455246
- Mean Citation Score: 570.108426
- Max Citation Score: 694.43365
- Similarity Product: 561.8470413005739

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test